Salman Tary, Elsabaawy Maha, Omar Mahmoud, Afify Mohamed, Elezawy Hossam, Ghanem Samar, Abdelraouf Osama, Rewisha Eman, Shebl Nashwa
National Liver Institute, Menoufia University, Egypt.
Faculty of Computers and Information, Menoufia University, Egypt.
Clin Exp Hepatol. 2021 Sep;7(3):312-319. doi: 10.5114/ceh.2021.109292. Epub 2021 Sep 23.
Minimal hepatic encephalopathy (MHE) represents one of the most overlooked complications of liver cirrhosis.
To compare the utility and efficacy of different MHE diagnostic modalities.
This case-control study was conducted on hepatitis C virus (HCV)-related compensated cirrhotic patients. The Psychometric Hepatic Encephalopathy Score (PHES) was used to assign patients to MHE and controls. All patients were subjected to plasma ammonia, serum 3-nitrotyrosine (3-NT), critical flicker frequency (CFF), and the modified inhibitory control test (ICT).
CFF was significantly lower in the control group (38.5, 40 Hz, = 0.003). The unweighted lures on ICT were 8.7, 4.9 in MHE and controls ( < 0.001). Moreover, ammonia was higher in the MHE group (89, 61.5 µmol/l, < 0.001). 3-NT was also higher in the MHE group (31.5, 13.7 nmol/l, < 0.001) respectively. CFF at cutoff < 39 Hz had sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 57.5%, 77.5%, 71.9% and 64.6%, respectively; in modified ICT, at cutoff > 5 unweighted lures the values were 87.5%, 80%, 81.4% and 86.5%, respectively; in ammonia, at cutoff ≥ 76.45 µmol/l the values were 65%, 72.5%, 70.3% and 67.4%, respectively; for 3-NT at cutoff ≥ 14.15 nmol/l the values were 85%, 82.5%, 82.9% and 84.6%, respectively. The accuracy for MHE diagnosis was 67.5%, 83.3%, 68.8%, 83.8% relying on CFF, 3-NT, ammonia, and ICT respectively. On multivariate analysis, CFF < 39 Hz (OR = 10.2, = 0.04), modified ICT > 5 unweighted lures (OR = 43.2, = 0.002), and serum 3-NT levels ≥ 14.15 nmol/l (OR = 50.4, < 0.001) were independent predictors of MHE.
3-NT and ICT are advantageous to reveal MHE in compensated liver cirrhosis, while CFF can be only used as adjuncts, with humble merits of ammonia.
轻微肝性脑病(MHE)是肝硬化最易被忽视的并发症之一。
比较不同MHE诊断方法的实用性和有效性。
本病例对照研究针对丙型肝炎病毒(HCV)相关的代偿期肝硬化患者开展。采用心理测量肝性脑病评分(PHES)将患者分为MHE组和对照组。所有患者均接受血浆氨、血清3-硝基酪氨酸(3-NT)、临界闪烁频率(CFF)以及改良抑制控制测试(ICT)。
对照组的CFF显著更低(38.5,40Hz,P = 0.003)。MHE组和对照组在ICT上的未加权诱捕数分别为8.7、4.9(P < 0.001)。此外,MHE组的氨水平更高(89,61.5µmol/l,P < 0.001)。MHE组的3-NT也更高(31.5,13.7nmol/l,P < 0.001)。截止值< 39Hz时,CFF的灵敏度、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为57.5%、77.5%、71.9%和64.6%;在改良ICT中,截止值> 5个未加权诱捕数时,相应值分别为87.5%、80%、81.4%和86.5%;对于氨,截止值≥ 76.45µmol/l时,相应值分别为65%、72.5%、70.3%和67.4%;对于3-NT,截止值≥ 14.15nmol/l时,相应值分别为85%、82.5%、82.9%和84.6%。依靠CFF、3-NT、氨和ICT诊断MHE的准确率分别为67.5%、83.3%、68.8%、83.8%。多因素分析显示,CFF < 39Hz(OR = 10.2,P = 0.04)、改良ICT > 5个未加权诱捕数(OR = 43.2,P = 0.002)以及血清3-NT水平≥ 14.15nmol/l(OR = 50.4,P < 0.001)是MHE的独立预测因素。
3-NT和ICT在揭示代偿期肝硬化中的MHE方面具有优势,而CFF仅可作为辅助手段,氨的作用较小。